all report title image

RENAL DENERVATION DEVICES MARKET ANALYSIS

Renal Denervation Devices Market, By Procedure Type (Percutaneous Renal Denervation, Radiofrequency Renal Denervation, Ultrasound Renal Denervation, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In : Jan 2024
  • Code : CMI798
  • Pages :138
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market News

Recent Developments

New Product Launches

  • In November 17, 2023, Medtronic, a medical device company, received approval from the U.S. Food and Drug Administration (FDA) Medtronic Symplicity Spyral renal denervation system for use in the U.S.
  • In November 10, 2023, Recor Medical, Inc., a medical device company, announced the first commercial use of Recor’s Paradise Ultrasound Renal Denervation (uRDN) system for the treatment of hypertension, the first U.S.FDA approved renal denervation therapy in the U.S.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.